Microparticles and type 2 diabetes
- 29 February 2008
- journal article
- Published by Elsevier BV in Diabetes & Metabolism
- Vol. 34, 27-32
- https://doi.org/10.1016/s1262-3636(08)70100-9
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Circulating MicroparticlesHypertension, 2006
- Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stressBlood, 2006
- Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery diseaseEuropean Heart Journal, 2006
- Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimizationProteomics, 2006
- Dying for attention: Microparticles and angiogenesisCardiovascular Research, 2005
- Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levelsDiabetic Medicine, 2005
- Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitusJournal of Human Hypertension, 2005
- Measuring circulating cell‐derived microparticlesJournal of Thrombosis and Haemostasis, 2004
- Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathwayBiochemical and Biophysical Research Communications, 2004
- Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb‐IIIa antagonistsJournal of Thrombosis and Haemostasis, 2004